A phase II pilot clinical study of experimental research to evaluate the functional rescue of CFTR protein through proteostasis regulators

Trial Profile

A phase II pilot clinical study of experimental research to evaluate the functional rescue of CFTR protein through proteostasis regulators

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs Mercaptamine bitartrate (Primary) ; Epigallocatechin gallate
  • Indications Cystic fibrosis
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 02 Mar 2016 Status changed from recruiting to completed, according to European Clinical Trials Database record.
    • 11 Jul 2015 Planned number of patients changed from 10 to 60, according to European Clinical Trials Database record.
    • 02 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top